The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Epperson, N.
* Articles by Anderson, G. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Epperson, N.
* Articles by Anderson, G. M.
Related Collections
* Neurotransmitters
* Gender
* Depression
* Antidepressants
Am J Psychiatry 158:1631-1637, October 2001
© 2001 American Psychiatric Association


Article

Maternal Sertraline Treatment and Serotonin Transport in Breast-Feeding Mother-Infant Pairs

Neill Epperson, M.D., Kathryn A. Czarkowski, M.A., Deborah Ward-O’Brien, M.S.N., A.P.R.N., Erica Weiss, M.D., Ralitza Gueorguieva, Ph.D., Peter Jatlow, M.D., and George M. Anderson, Ph.D.

OBJECTIVE: Pharmacological treatment of postpartum depression is frequently complicated by the mother’s desire to breast-feed. Although breast milk levels of several selective serotonin reuptake inhibitors (SSRIs) have been reported to be relatively low, a critical question is whether SSRI exposure during nursing results in clinically significant blockade of serotonin (5-HT) reuptake in infants. This study determined the degree of transporter blockade in infants exposed to sertraline through maternal breast milk. METHOD: The extent of maternal and infant transporter blockade was assessed by measurement of platelet levels of 5-HT in 14 breast-feeding mother-infant pairs before and after 6–16 weeks of maternal treatment with sertraline for major depression with postpartum onset. Plasma sertraline and desmethylsertraline levels were obtained in 13 of these mothers and 11 of their infants. RESULTS: Marked declines in platelet 5-HT levels of 70%–96% were observed in mothers after sertraline treatment, 25–200 mg/day. In contrast, infants showed little or no change in platelet 5-HT levels after exposure through breast-feeding. Mean levels of maternal plasma sertraline and its major metabolite, desmethylsertraline, were 30.7 ng/ml and 45.3 ng/ml, respectively. Drug and drug metabolite concentrations in the infants were at or below the lower limit of quantitation. CONCLUSIONS: The data indicate that while mothers receiving clinical doses of sertraline experience substantial blockade of the platelet 5-HT transporter, platelet 5-HT uptake in nursing infants of treated mothers is unaltered. The observations suggest that mothers taking sertraline can breast-feed without appreciably affecting peripheral or central 5-HT transport in their infants.




This article has been cited by other articles:


Home page
PediatricsHome page
F. Fortinguerra, A. Clavenna, and M. Bonati
Psychotropic Drug Use During Breastfeeding: A Review of the Evidence
Pediatrics, October 1, 2009; 124(4): e547 - e556.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
ACOG Practice Bulletin
Clinical Management Guidelines for Obstetrician-Gynecologists Use of Psychiatric Medications During Pregnancy and Lactation
Focus, July 1, 2009; 7(3): 385 - 400.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
D. Kohen
Psychotropic medication and breast-feeding
Adv. Psychiatr. Treat., September 1, 2005; 11(5): 371 - 379.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. M. Weissman, B. T. Levy, A. J. Hartz, S. Bentler, M. Donohue, V. L. Ellingrod, and K. L. Wisner
Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants
Am J Psychiatry, June 1, 2004; 161(6): 1066 - 1078.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. N. Epperson, P. I. Jatlow, K. Czarkowski, and G. M. Anderson
Maternal Fluoxetine Treatment in the Postpartum Period: Effects on Platelet Serotonin and Plasma Drug Levels in Breastfeeding Mother-Infant Pairs
Pediatrics, November 1, 2003; 112(5): e425 - 425.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
D. Gjerdingen
The Effectiveness of Various Postpartum Depression Treatments and the Impact of Antidepressant Drugs on Nursing Infants
J Am Board Fam Med, September 1, 2003; 16(5): 372 - 382.
[Abstract] [Full Text]


Home page
J Hum LactHome page
E. J. Begg, S. B. Duffull, L. P. Hackett, and K. F. Ilett
Studying Drugs in Human Milk: Time to Unify the Approach
J Hum Lact, November 1, 2002; 18(4): 323 - 332.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
V. Hendrick and L. Altshuler
Management of Major Depression During Pregnancy
Am J Psychiatry, October 1, 2002; 159(10): 1667 - 1673.
[Full Text] [PDF]


Home page
NEJMHome page
K. L. Wisner, B. L. Parry, and C. M. Piontek
Postpartum Depression
N. Engl. J. Med., July 18, 2002; 347(3): 194 - 199.
[Full Text] [PDF]


Home page
JWatch PediatricsHome page
Serotonin Reuptake Is Normal in Breast-Feeding Infants of SSRI-Treated Mothers
Journal Watch Pediatrics and Adolescent Medicine, February 8, 2002; 2002(208): 22 - 22.
[Full Text]


Home page
JWatch PsychiatryHome page
Serotonin Reuptake is Normal in Breast-feeding Infants of SSRI-Treated Mothers
Journal Watch Psychiatry, January 24, 2002; 2002(124): 15 - 15.
[Full Text]


Home page
JWatch Women's HealthHome page
Serotonin Reuptake Is Normal in Nursing Infants of SSRI-Treated Mothers
Journal Watch Women's Health, December 5, 2001; 2001(1205): 1 - 1.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org